146 related articles for article (PubMed ID: 12605033)
41. Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.
Tebbit CL; Zhai J; Untch BR; Ellis MJ; Dressman HK; Bentley RC; Baker JA; Marcom PK; Nevins JR; Marks JR; Olson JA
Breast Cancer Res Treat; 2009 Dec; 118(3):635-43. PubMed ID: 19224362
[TBL] [Abstract][Full Text] [Related]
42. Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker.
Liu JJ; Shen R; Chen L; Ye Y; He G; Hua K; Jarjoura D; Nakano T; Ramesh GK; Shapiro CL; Barsky SH; Gao JX
Int J Clin Exp Pathol; 2010 Mar; 3(4):328-37. PubMed ID: 20490325
[TBL] [Abstract][Full Text] [Related]
43. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay.
Perreard L; Fan C; Quackenbush JF; Mullins M; Gauthier NP; Nelson E; Mone M; Hansen H; Buys SS; Rasmussen K; Orrico AR; Dreher D; Walters R; Parker J; Hu Z; He X; Palazzo JP; Olopade OI; Szabo A; Perou CM; Bernard PS
Breast Cancer Res; 2006; 8(2):R23. PubMed ID: 16626501
[TBL] [Abstract][Full Text] [Related]
44. Protein expression profile and prevalence pattern of the molecular classes of breast cancer--a Saudi population based study.
Al Tamimi DM; Shawarby MA; Ahmed A; Hassan AK; AlOdaini AA
BMC Cancer; 2010 May; 10():223. PubMed ID: 20492711
[TBL] [Abstract][Full Text] [Related]
45. HER2 in gastric cancer: comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays.
Abrahão-Machado LF; Jácome AA; Wohnrath DR; dos Santos JS; Carneseca EC; Fregnani JH; Scapulatempo-Neto C
World J Gastroenterol; 2013 Oct; 19(38):6438-46. PubMed ID: 24151362
[TBL] [Abstract][Full Text] [Related]
46. A prognostic test for adenocarcinoma of the lung from gene expression profiling data.
Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202
[TBL] [Abstract][Full Text] [Related]
47. Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.
Colombo PE; Milanezi F; Weigelt B; Reis-Filho JS
Breast Cancer Res; 2011 Jun; 13(3):212. PubMed ID: 21787441
[TBL] [Abstract][Full Text] [Related]
48. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM
Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180
[TBL] [Abstract][Full Text] [Related]
49. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
50. Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes.
Stefansson OA; Jonasson JG; Johannsson OT; Olafsdottir K; Steinarsdottir M; Valgeirsdottir S; Eyfjord JE
Breast Cancer Res; 2009; 11(4):R47. PubMed ID: 19589159
[TBL] [Abstract][Full Text] [Related]
51. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.
Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB
Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979
[TBL] [Abstract][Full Text] [Related]
52. Breast cancer pathology: the impact of molecular taxonomy on morphological taxonomy.
Masuda S
Pathol Int; 2012 May; 62(5):295-302. PubMed ID: 22524656
[TBL] [Abstract][Full Text] [Related]
53. Differential gene expression profiles according to the Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society histopathological classification in lung adenocarcinoma subtypes.
Molina-Romero C; Rangel-Escareño C; Ortega-Gómez A; Alanis-Funes GJ; Avilés-Salas A; Avila-Moreno F; Mercado GE; Cardona AF; Hidalgo-Miranda A; Arrieta O
Hum Pathol; 2017 Aug; 66():188-199. PubMed ID: 28603066
[TBL] [Abstract][Full Text] [Related]
54. Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.
Bertucci F; Finetti P; Rougemont J; Charafe-Jauffret E; Cervera N; Tarpin C; Nguyen C; Xerri L; Houlgatte R; Jacquemier J; Viens P; Birnbaum D
Cancer Res; 2005 Mar; 65(6):2170-8. PubMed ID: 15781628
[TBL] [Abstract][Full Text] [Related]
55. Clinical validation of a customized multiple signature microarray for breast cancer.
Tan BK; Tan LK; Yu K; Tan PH; Lee M; Sii LH; Wong CY; Ho GH; Yeo AW; Chow PK; Koong HN; Yong WS; Lim DT; Ooi LL; Soo KC; Tan P
Clin Cancer Res; 2008 Jan; 14(2):461-9. PubMed ID: 18223220
[TBL] [Abstract][Full Text] [Related]
56. Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.
O Leary PC; Penny SA; Dolan RT; Kelly CM; Madden SF; Rexhepaj E; Brennan DJ; McCann AH; Pontén F; Uhlén M; Zagozdzon R; Duffy MJ; Kell MR; Jirström K; Gallagher WM
BMC Cancer; 2013 Apr; 13():175. PubMed ID: 23547718
[TBL] [Abstract][Full Text] [Related]
57. 72-gene classifier for predicting prognosis of estrogen receptor-positive and node-negative breast cancer patients using formalin-fixed, paraffin-embedded tumor tissues.
Nishio M; Naoi Y; Tsunashima R; Nakauchi C; Kagara N; Shimoda M; Shimomura A; Maruyama N; Shimazu K; Kim SJ; Noguchi S
Clin Breast Cancer; 2014 Jun; 14(3):e73-80. PubMed ID: 24461457
[TBL] [Abstract][Full Text] [Related]
58. Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.
Jumppanen M; Gruvberger-Saal S; Kauraniemi P; Tanner M; Bendahl PO; Lundin M; Krogh M; Kataja P; Borg A; Fernö M; Isola J
Breast Cancer Res; 2007; 9(1):R16. PubMed ID: 17263897
[TBL] [Abstract][Full Text] [Related]
59. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
[TBL] [Abstract][Full Text] [Related]
60. Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays.
Mobasheri A; Airley R; Hewitt SM; Marples D
Int J Oncol; 2005 May; 26(5):1149-58. PubMed ID: 15809704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
